Gold nanoparticle incorporated polymer/bioactive glass composite for controlled drug delivery application

Colloids and Surfaces B: Biointerfaces

Volumn 126, Issue , 2015, Pages 280-287

  Jayalekshmi, A C ^a   Sharma, Chandra P ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Bioglass; Chitosan; Composite; Drug delivery; Gelatin; Gold nanoparticles

Indexed keywords

ATOMIC FORCE MICROSCOPY; BIOACTIVE GLASS; BIODEGRADABLE POLYMERS; CHITOSAN; COMPOSITE MATERIALS; DRUG DELIVERY; FLUORESCENCE; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GOLD; LOADING; METAL NANOPARTICLES; NANOPARTICLES; QUENCHING; TEMPERATURE; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION;

AGGREGATION BEHAVIOURS; DRUG DELIVERY APPLICATIONS; FLUORESCENCE QUENCHING EFFECT; GELATIN; GOLD NANOPARTICLES; LOW TEMPERATURE METHOD; NEGATIVE ZETA POTENTIALS; PHOSPHATE-BUFFERED SALINES;

CONTROLLED DRUG DELIVERY;

DOXORUBICIN; GOLD NANOPARTICLE; POLYMER; GLASS; GOLD; METAL NANOPARTICLE;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED RELEASE FORMULATION; DEGRADATION; DISSOLUTION; DRUG DELIVERY SYSTEM; INFRARED SPECTROSCOPY; MORPHOLOGY; PARTICLE SIZE; PHOTOCHEMICAL QUENCHING; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY; X RAY DIFFRACTION; ZETA POTENTIAL; CHEMISTRY; SURFACE PROPERTY; TEMPERATURE;

DOXORUBICIN; DRUG DELIVERY SYSTEMS; GLASS; GOLD; METAL NANOPARTICLES; PARTICLE SIZE; POLYMERS; SURFACE PROPERTIES; TEMPERATURE;

EID: 84920733574     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.12.021     Document Type: Article

References (60)

1. Cheng X., Kuhn L. Chemotherapy drug delivery from calcium phosphate nanoparticles. Int. J. Nanomed. 2007, 2:667-674.
2. Verron E., Khairoun I., Guicheux J., Bouler J.-M. Calcium phosphate biomaterials as bone drug delivery systems: a review. Drug Discov. Today 2010, 15:547-552.
3. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., Higuichi W.I. A novel skeletal drug delivery system using a self-setting calcium phosphate cement. 5. Drug release behavior from a heterogeneous drug-loaded cement containing an anticancer drug. J. Pharm. Sci. 1994, 83:1565-1568.
4. Rim H.P., Min K.H., Lee H.J., Jeong S.J., Lee S.C. pH-tunable calcium phosphate covered mesoporous silica nano containers for intra cellular controlled release of guest drugs. Angew. Chem. Int. Ed. 2011, 50:8853-8857.
5. He C., Xiao G., Jin X., Sun C., Ma P.X. Electrodeposition on nanofibrous polymer scaffolds: rapid mineralization, tunable calcium phosphate composition and topography. Adv. Funct. Mater. 2010, 20:3568-3576.
6. Banerjee S.S., Roy M., Bose S. pH tunable fluorescent calcium phosphate nanocomposite for sensing and controlled drug delivery. Adv. Eng. Mater. B 2011, (1-2):B10-B17.
7. Koerten H.K., Meulen van der J. Degradation of calcium phosphate ceramics. J. Biomed. Mater. Res. 1999, 44:78-86.
8. Arinzeh T.L., Tran T., Mcalary J., Daculsi G. A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials 2005, 26:3631-3638.
9. Regí M.V., Calbet J.M.G. Calcium phosphate as substitution of bone tissues. Progr. Solid State Chem. 2004, 32:1-31.
10. LeGeros R.Z. Biodegradation and bioresorption of calcium phosphate ceramics. Clin. Mater. 1993, 14:65-88.
11. Xue W., Bandyopadhyay A., Bose S. Polycaprolactone coated porous tricalcium phosphate scaffolds for controlled release of protein for tissue engineering. J. Biomed Mater Res. Part B: Appl. Biomater. 2009, 91:831-838.
12. Paul W., Sharma C.P. Ceramic drug delivery: a perspective. J. Biomater. Appl. 2003, 17:253-264.
13. Sahoo S.K., Labhasetwar V. Nanotech approach to drug delivery and imaging. Drug Discov. Today 2003, 8:1112-1120.
14. Habraken W.J.E.M., Wolke J.G.C., Jansen J.A. Ceramic nanocomposites as matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 2007, 59:234-248.
15. Uchida A., Shinto Y., Araki N., Ono K. Slow release of anticancer drugs from porous calcium phosphate ceramic. J. Orthop. Res. 1992, 10:440-445.
16. Rezwan K., Chen Q.Z., Blaker J.J., Boccaccini A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006, 27:3413-3431.
17. Mouriňo V., Boccaccini A.R. Bone tissue engineering therapeutics: controlled drug delivery in three dimensional scaffolds. J. R. Soc. Interface 2010, 7:209-227.
18. Lin H.-M., Wang W.-K., Hsiung P.-A., Shyu S.-G. Light-sensitive intelligent drug delivery systems of coumarin-modified mesoporous bioactive glass. Acta Biomater. 2010, 6:3256-3263.
19. Pitukmanorom P., Yong T.-H., Ying J.Y. Tunable release of proteins with polymer-inorganic nanocomposite microspheres. Adv. Mater. 2008, 20:3504-3509.
20. Zhang Y., Zhang M. Calcium phosphate/chitosan composite scaffolds for controlled in-vitro antibiotic drug release. J. Biomed. Mater. Res. 2002, 62:378-386.
21. Perkin K.K., Turner J.L., Wooley K.L., Mann S. Fabrication of hybrid nanocapsules by calcium phosphate mineralization of shell cross-linked polymer micelles and nanocages. Nano Lett. 2005, 5:1457-1461.
22. Mitra S., Gaur U., Ghosh P.C., Maitra A.N. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Controll. Release 2001, 74:317-323.
23. Heinemann S., Heinemann C., Wenisch S., Alt V., Worch H., Hanke T. Calcium phosphate phases integrated in silica/collagen nanocomposite xerogels enhance the bioactivity and ultimately manipulate the osteoblast/osteoclast ratio in a human co-culture model. Acta Biomater. 2013, 9:4878-4888.
24. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloid Surf. B: Biointerfaces 2010, 75:1-18.
25. Muzzarelli R., Baladassarre V., Conti F., Ferrara P., Blagini G., Gazzanelli C., Vasi V. Biological activity of chitosan: ultrastructural study. Biomaterials 1988, 9:247-252.
26. Risbud M.V., Hardikar A.A., Bhat S.V., Bhonde R.R. pH sensitive freeze-dried chitosan-polyvinylpyrrolidone hydrogels as controlled release system for antibiotic delivery. J. Controll. Release 2000, 68:23-30.
27. Berger J., Reist M., Mayer J.M., Felt O., Peppas N.A., Gurny R. Structure and interactions in covalently and ionically cross linked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57:19-34.
28. Iyer P., Walker K.J., Madihally S.V. Increased matrix synthesis by fibroblasts with decreased proliferation on synthetic chitosan-gelatin porous structures. Biotech. Bioeng. 2012, 109:1314-1325.
29. Silvio D.L., Harris R.G.C., Downes S. The use of gelatin as a vehicle for drug and peptide delivery. J. Mater. Sci.: Mater. Med. 1994, 5:819-823.
30. Naidu B.V.K., Paulson A.T. A new method for the preparation of gelatin nanoparticles: encapsulation and drug release characteristics. J. Appl. Polym. Sci. 2011, 121:3495-3500.
31. Aina V., Marchis T., Laurenti E., Diana E., Lusvardi G., Malavasi G., Menabue L., Cerrato G., Morterra C. Functionalization of sol-gel bioactive glass carrying Au nanoparticles: selective Au affinity for amino and thiol ligand groups. Langmuir 2010, 26:18600-18605.
32. Simon S., Lucacel R.C., Radu T., Baia L., Ponta O., Iepure A., Simon V. Gold nanoparticles developed in sol-gel derived apatite-bioactive glass composites. J. Mater. Sci.: Mater. Med. 2012, 23:1193-1201.
33. Ekaterina Y., Helb L., Belyanin A., Kashinath S., Wu X., Lapotko D.O. Plasmonic nanobubble enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug resistant cancer cells. Biomaterials 2012, 33:1821-1826.
34. Zhang G., Yang Z., Lu W., Zhang R., Huang Q., Tian M., Li L., Liang D., Li C. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009, 30:1928-1936.
35. Prabaharan M., Grailer J.J., Pilla S., Steeber A., Gong S. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor targeted drug delivery. Biomaterials 2009, 30:6065-6075.
36. Ahn S., Jung S.Y., Seo E., Lee S.J. Gold nanoparticles incorporated human red blood cells (RBCs) for X-ray dynamic imaging. Biomaterials 2011, 32:7191-7199.
37. Lee K., Lee H., Bae K.H., Park T.G. Heparin immobilized gold nanoparticles for targeted detection and apoptotic death of metastatic cancer cells. Biomaterials 2010, 31:6530-6536.
38. Zhou X., Zhang X., Yu X., et al. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. Biomaterials 2008, 29:111-117.
39. Hersh L.R., Stafford R.J., et al. Nanoshell-mediated near infra red thermal therapy of tumors under magnetic resonance guide. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13549-13554.
40. Krpetic Z., Porta F., Caneva E., Santo V.D., Scari G. Phagocytosis of biocompatible gold nanoparticles. Langmuir 2010, 26:14799-14805.
41. Lusvardi G., Malavasi G., Aina V., Bertinetti L., Cerrato G., Magnacca G., Morterra C., Menabue L. Bioactive glasses containing Au nanoparticles. Effect of calcinations temperature on structure, morphology and surface properties. Langmuir 2010, 26:10303-10314.
42. Park H., Yang J., Lee J., Haam S., Choi I.H., Yoo K.H. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano 2009, 3:2919-2926.
43. Nawara K., Romiszewski J., Kijewska K., Szczytko J., Twardowski A., Mazur M., Krysinski P. Adsorption of doxorubicin onto citrate-stabilized magnetic nanoparticles. J. Phys. Chem. C. 2012, 116:5598-5609.
44. Wang F., Wang Y.C., Dou S., Xiong M.H., Sun T.M., Wang J. Doxorubicin tethered responsive gold nano particles facilitate intracellular drug delivery for overcoming multi drug resistance in cancer cells. ACS Nano 2011, 5:3679-3692.
45. Xie J., Zhang Y., Ying J.Y. Protein-directed synthesis of highly fluorescent gold nanoclusters. J. Am. Chem. Soc. 2009, 131:888-889.
46. Durgadas C.V., Sharma C.P., Srinivasan K. Fluorescent gold clusters as nanosensors for copper ions in liver cells. Analyst 2011, 136:933-940.
47. Jayalekshmi A.C., Victor S.P., Sharma C.P. Magnetic and degradable polymer/bioactive glass composite nanoparticles for biomedical applications. Colloid Surf. B: Biointerfaces 2013, 101:196-204.
48. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 1970, 227:680-685.
49. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
50. Clupper D.C., Mecholsky J.J., LaTorre G.P., Greenspan D.C. Bioactivity of tapecast and sintered bioactive glass-ceramic in simulated body fluid. Biomaterials 2002, 23:2599-2606.
51. 2 glass-ceramics. J. Non-Cryst. Solids 2001, 292:115-126.
52. Qian J., Kang Y., Wei Z., Zhang W. Fabrication and characterization of biomorphic 45S5 bioglass scaffold from sugarcane. Mater. Sci. Eng. C 2009, 29:1361-1364.
53. Fuji E., Ohkubo M., Tsuru K., Hayakawa S., Osaka A., Kawabata K., Bonhomme C., Babonneau F. Selective protein adsorption property and characterization of nano-crystalline zinc containing hydroxyapatite. Acta Biomater. 2006, 2:69-74.
54. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating nanoparticles: theory to practice. Pharmacol. Rev. 2001, 53:283-318.
55. Barbè C., Bartlett J., Kong L., Finnie K., Lin H.Q., Larkin M., Calleja S., Bush A., Calleja G. Silica particles: a novel drug delivery system. Adv. Mater. 2004, 16:1-8.
56. Bernabeu P., Caprani A. Influence of surface charge on adsorption of fibrinogen and/or albumin on a rotating disc electrode of platinum and carbon. Biomaterials 1990, 11:258-264.
57. Griffin J., Singh A.K., Senapati D., Rhodin P., Mitchell K., Robinson B., Yu E., Ray P.C. Size- and distance-dependent nanoparticles surface energy transfer (NSET) method for selective sensing of Hepatitis C virus RNA. Chem. Eur. J. 2009, 15:342-351.
58. Chen Y., O'Donoghue M.B., Huang Y.F., Kang H.Z., Phillips J.A., Chen X.L., Estevez M.C., Yang C.Y.J., Tan W.H.A. Surface energy transfer nanoruler for measuring binding site distances on live cell surfaces. J. Am. Chem. Soc. 2010, 132:16559-16570.
59. Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989, 49:4373-4384.
60. Meledandri C.J., Stolarczyk J.K., Brougham D.F. Hierarchial gold-decorated magnetic nanoparticle clusters with controlled size. ACS Nano 2011, 5:1747-1755.